Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

Conditions

Subcategories:Axial Spondyloarthritis Clinical Criteria/Guidelines Gout and Crystalline Arthritis Myositis Osteoarthritis and Bone Disorders Other Rheumatic Conditions Pain Syndromes Pediatric Conditions Psoriatic Arthritis Rheumatoid Arthritis Sjögren’s Disease Soft Tissue Pain Systemic Lupus Erythematosus Systemic Sclerosis Vasculitis

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD | March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

Tackle Tricky Lung Complications in Connective Tissue Disease

Susan Bernstein | February 15, 2013

Guidance for diagnosing and treating interstitial lung disease complications

First Annual Rheumatoid Awareness Day to Be Held February 2

Michael O’Neal | February 2, 2013

New day of action and outreach aims to spread awareness of rheumatoid arthritis

How to Evaluate Shoulder Pain

Nitin B. Jain, MD, MSPH | February 2, 2013

The common causes of shoulder pain and diagnostic tests that rheumatologists need to know

ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies

Susan Bernstein | February 1, 2013

The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

Thomas R. Collins | February 1, 2013

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs

ACR/ARHP Annual Meeting 2012: Will Novel Strategies Lead to Breakthroughs in Treating Osteoarthritis?

Susan Bernstein | February 1, 2013

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein | February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

Letter: Praise for SAPHO Syndrome Article

Nils Erikson, MD, and Marcel Francis Kahn, MD | February 1, 2013

After reading your article on SAPHO, I may get a better treatment plan for my patient; thanks for drawing the attention of American College of Rheumatology members to an obscure condition that can vex patients and clinicians

ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis

Mary Beth Nierengarten | February 1, 2013

Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists